Skip to main content

Protara Therapeutics, Inc.

TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001359931

In the last 90 days, Protara Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.

13F holders, Q2 2021

Institutional positions in Protara Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
40
−10 vs. Q1 2021
Shares held
7.11M
−1.42M (−16.6%) vs. Q1 2021
Total value
$69.3M
−$64.8M (−48.3%) vs. Q1 2021
New holders
9
8 more added
Sold out
19
18 more reduced

Compare with Q1 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TARA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2021: 40 institutions
Q1 2021: 50 institutionsQ2 2021: 40 institutionsQ3 2021: 36 institutionsQ4 2021: 38 institutionsQ1 2022: 35 institutionsQ2 2022: 33 institutionsQ3 2022: 31 institutionsQ4 2022: 30 institutionsQ1 2023: 29 institutionsQ2 2023: 29 institutionsQ3 2023: 31 institutionsQ4 2023: 30 institutionsQ1 2024: 34 institutionsQ2 2024: 38 institutionsQ3 2024: 35 institutionsQ4 2024: 60 institutionsQ1 2025: 59 institutionsQ2 2025: 76 institutionsQ3 2025: 81 institutionsQ4 2025: 105 institutionsQ1 2026: 114 institutionsQ2 2026: 119 institutions
Value heldQ2 2021: $69.3M
Q1 2021: $134.0MQ2 2021: $69.3MQ3 2021: $43.7MQ4 2021: $46.5MQ1 2022: $33.2MQ2 2022: $18.4MQ3 2022: $16.7MQ4 2022: $14.7MQ1 2023: $16.9MQ2 2023: $12.3MQ3 2023: $8.55MQ4 2023: $8.17MQ1 2024: $18.3MQ2 2024: $22.2MQ3 2024: $19.1MQ4 2024: $156.6MQ1 2025: $123.8MQ2 2025: $90.1MQ3 2025: $114.0MQ4 2025: $212.3MQ1 2026: $237.4MQ2 2026: $176.0M
Institutions holding TARA and their total value by quarter
QuarterHoldersValue
Q2 2026119$176.0M
Q1 2026114$237.4M
Q4 2025105$212.3M
Q3 202581$114.0M
Q2 202576$90.1M
Q1 202559$123.8M
Q4 202460$156.6M
Q3 202435$19.1M
Q2 202438$22.2M
Q1 202434$18.3M
Q4 202330$8.17M
Q3 202331$8.55M
Q2 202329$12.3M
Q1 202329$16.9M
Q4 202230$14.7M
Q3 202231$16.7M
Q2 202233$18.4M
Q1 202235$33.2M
Q4 202138$46.5M
Q3 202136$43.7M
Q2 202140$69.3M
Q1 202150$134.0M

Institutions, Q2 2021

Shares, value and share of portfolio for each institution holding Protara Therapeutics, Inc.; share changes are against Q1 2021.

Institutions holding TARA in Q2 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Opaleye Management Inc.2,558,472$24.9M4.14%00.0%Unchanged
Rock Springs Capital Management LP693,542$6.75M0.13%+3,600+0.5%Added
Ikarian Capital, LLC584,804$5.70M1.02%−64,738−10.0%Reduced
OrbiMed Advisors LLC450,000$4.38M0.04%00.0%Unchanged
Vanguard Group Inc437,108$4.26M0.00%−19,425−4.3%Reduced
Perceptive Advisors LLC421,641$4.11M0.05%−10.0%Reduced
Franklin Resources Inc350,010$3.41M0.00%00.0%Unchanged
Citadel Advisors LLC342,021$3.33M0.00%+100,507+41.6%Added
Boxer Capital, LLC209,227$2.04M0.07%00.0%Unchanged
Baker Bros. Advisors LP199,671$1.95M0.01%00.0%Unchanged
Goldman Sachs Group Inc132,257$1.29M0.00%+132,257New
Millennium Management LLC129,380$1.26M0.00%+69,246+115.2%Added
Geode Capital Management, LLC82,985$808.0K0.00%−28,077−25.3%Reduced
Two Sigma Advisers, LP58,318$568.0K0.00%+46,200+381.3%Added
Boothbay Fund Management, LLC56,883$554.0K0.02%−1,343−2.3%Reduced
Two Sigma Investments, LP55,405$540.0K0.00%+55,405New
Renaissance Technologies LLC51,427$501.0K0.00%+20,027+63.8%Added
Morgan Stanley48,884$475.0K0.00%+47,528+3,505.0%Added
BlackRock Inc.40,125$391.0K0.00%−149,751−78.9%Reduced
Knott David M36,164$352.0K0.14%+21,795+151.7%Added
Schonfeld Strategic Advisors LLC24,455$238.0K0.00%+1,000+4.3%Added
Northern Trust Corp22,279$217.0K0.00%−34,397−60.7%Reduced
Susquehanna International Group, LLP20,609$201.0K0.00%+20,609New
Bank of New York Mellon Corp17,907$174.0K0.00%−7,778−30.3%Reduced
Ergoteles LLC17,700$172.0K0.00%+17,700New
Marshall Wace, LLP17,469$170.0K0.00%−24,667−58.5%Reduced
Jane Street Group, LLC13,678$133.0K0.00%+13,678New
HRT Financial LP12,151$118.0K0.00%+12,151New
Prelude Capital Management, LLC11,700$114.0K0.01%+11,700New
State Street Corp10,359$101.0K0.00%−49,774−82.8%Reduced
Tower Research Capital LLC (TRC)1,548$15.0K0.00%−180−10.4%Reduced
Bank of America Corp932$9.00K0.00%−3,168−77.3%Reduced
Wells Fargo & Company559$6.00K0.00%−67,733−99.2%Reduced
Simplex Trading, LLC581$5.00K0.00%+581New
Retirement Group, LLC500$5.00K0.00%+500New
JPMorgan Chase & Co177$2.00K0.00%−1,376−88.6%Reduced
Panagora Asset Management Inc55$1.00K0.00%−5,866−99.1%Reduced
UBS Group AG99$1.00K0.00%−1,338−93.1%Reduced
New York State Common Retirement Fund29$00.00%−3,171−99.1%Reduced
Citigroup Inc15$00.00%−242−94.2%Reduced
CBIZ Investment Advisory Services, LLC0$00.00%–Sold out
Artisan Partners Limited Partnership0$00.00%−379,946−100.0%Sold out
Cormorant Asset Management, LP0$00.00%−350,000−100.0%Sold out
Price T Rowe Associates Inc0$00.00%−319,326−100.0%Sold out
Maven Securities LTD0$00.00%−172,177−100.0%Sold out
Alyeska Investment Group, L.P.0$00.00%−109,405−100.0%Sold out
Bank of Montreal0$00.00%−61,742−100.0%Sold out
Granahan Investment Management Inc0$00.00%−52,026−100.0%Sold out
TD Asset Management Inc0$00.00%−25,185−100.0%Sold out
Alps Advisors Inc0$00.00%−20,279−100.0%Sold out
Nuveen Asset Management, LLC0$00.00%−13,940−100.0%Sold out
Charles Schwab Investment Management Inc0$00.00%−12,060−100.0%Sold out
California State Teachers Retirement System0$00.00%−5,851−100.0%Sold out
Deutsche Bank AG0$00.00%−2,480−100.0%Sold out
American International Group, Inc.0$00.00%−2,254−100.0%Sold out
Royal Bank of Canada0$00.00%−969−100.0%Sold out
Legal & General Group Plc0$00.00%−492−100.0%Sold out
STRS Ohio0$00.00%−500−100.0%Sold out
Ameritas Investment Partners, Inc.0$00.00%−178−100.0%Sold out